Infusions Mark Tomlin Consultant Pharmacist: Critical Care Southampton University Hospitals NHS Trust.

Slides:



Advertisements
Similar presentations
Instant Clinical Pharmacology E.J. Begg
Advertisements

First, zero, pseudo-zero order elimination Clearance
Oxford University Hospitals NHS Trust Injectable medicines study day:
What is an IV push medication?
III. Drug Metabolism  The aim of drug metabolism is to convert lipid soluble (non polar) drugs to polar metabolites easily excreted in urine.  The liver.
Calculation of Doses I Dr. Osama A. A. Ahmed.
RATIONAL Prescribing & Prescription Writing Dr Arif Hashmi.
A physiological model of induction of anaesthesia with propofol in sheep. Jinfei Yu 05/31/2006 R. N. Upton and G. L. Ludbrook.
Chapter 3 Linear and Exponential Changes 3.2 Exponential growth and decay: Constant percentage rates 1 Learning Objectives: Understand exponential functions.
Pharmacokinetics -- part 1 --
Pharmacokinetics Questions
Multiple IV Dosing Pharmacokinetic Research, Bioequivalence Studies,
Index of Simulations 1-Compartment, IV bolus 1-Compartment, IV infusion: Steady- State1-Compartment, IV infusion: Steady- State 1-Compartment, IV infusion:
Laplace transformation
Practical Pharmacokinetics
Toxicokinetic Calculations
Preparing & administering Infusions Mark Tomlin Consultant Pharmacist: Critical Care Southampton University Hospitals NHS Trust.
Dosing Regimen Design Infusion regimen.
Module 2 # 3 Pharmacokinetics how to make sense of the previous lesson or why do I have to learn this stuff?
INTRAVENOUS INFUSION.
Dr. Rosaline Kinuthia Clinical pharmacist KNH. Optimize patients outcomes through the judicious, safe, efficacious, appropriate and cost effective use.
Excretion of Drugs By the end of this lecture, students should be able to Identify main and minor routes of Excretion including renal elimination and biliary.
VM 8314 Dr. Jeff Wilcke Pharmacokinetic Modeling (describing what happens)
University of Jordan-Faculty of Pharmacy
The General Concepts of Pharmacokinetics and Pharmacodynamics Hartmut Derendorf, PhD University of Florida.
PHARMACOKINETICS 1. Fate of drugs in the body 1.1 absorption
Objective: Explain the variation in dosing intervals for medications 1)Introduce Half-Life (t 1/2 ) 2)Relate Half-Life to Dosing intervals of aspirin and.
Pharmacokinetics Introduction
Case Study: Drug Dosage CS 170: Computing for the Sciences and Mathematics.
Lecture 2.  Clearance Ability to eliminate the drug  Volume of distribution (Vd) The measure of the apparent space in the body available to contain.
© 2004 by Thomson Delmar Learning, a part of the Thomson Corporation. Fundamentals of Pharmacology for Veterinary Technicians Chapter 3 Therapeutic Range.
PLASMA HALF LIFE ( t 1/2 ).  Minimum Effective Concentration (MEC): The plasma drug concentration below which a patient’s response is too small for clinical.
Pharmacology Department
Core Concepts in Pharmacology Chapter 5 Pharmacokinetics.
Chapter 35 Medication Administration. Scientific Knowledge Base To safely and accurately administer medications you need knowledge related to: ◦Pharmacology.
Intravenous Infusion Previous rates of administration were instantaneous IV bolus and first order absorption. As a rate (mg/hr) a first order rate constantly.
Multiple dosing: intravenous bolus administration
1 Single-dose kinetics Plasma [Drug] curve Upon administration [drug] plasma reaches a max Then begins to decline as the Drug is eliminated Cp max = max.
1. Fate of drugs in the body 1.1 absorption 1.2 distribution - volume of distribution 1.3 elimination - clearance 2. The half-life and its uses 3. Repeated.
Continuous intravenous infusion (one-compartment model)
Excretion of Drugs By the end of this lecture, students should be able to Identify main and minor routes of Excretion including renal elimination and biliary.
INTRODUCTION CLINICAL PHARMACOKINETICS
BIOPHARMACEUTICS.
1 Pharmacokinetics: Introduction Dr Mohammad Issa.
Principles of pharmacokinetics Prof. Kršiak Department of Pharmacology, Third Faculty of Medicine, Charles University in Prague Cycle II, Subject: General.
Prof. Dr. Henny Lucida, Apt
Therapeutic drug Monitoring
Design of Sustained Release Dosage Forms
Clinical Pharmacokinetic Equations and Calculations
DEFINITIONS T1/2 & Tmax Cmax AUC 1st order kinetics
Case 9 Amikacin in an elderly CKD patient Block 9 : Divine Ramos, Remonte, Reyes, Rivera A, Rivera K, Rivera M, Rogelio, Sagayaga, Santiago, See, Siy,
Objectives Compartment Modeling of Drugs Models describing drug concentration-time profiles Multi-compartment Models.
415 PHT Plasma Level – Time Curve
Learning objectives To know what data is available from pharmacokinetic studies in man and how to handle it To know how to calculate the basic pharmacokinetic.
Pharmacokinetic Questions
ICU Prescribing Made Easy 2015 Quick Guide to Safe Prescribing on Commonly Seen Drugs.
Pharmacokinetics 3rd Lecture
MULTIPLE DOSAGE REGIMEN
Drug Response Relationships
The aminoglycoside antibiotics
Pharmacokinetics Tutoring
PHARMACOKINETICS Allie punke
Controls and Functions
Quantitative Pharmacokinetics
Clinical Pharmacokinetics
Dose measurement Lecturer: dr. Asmaa abdelaziz Mohamed
Calculation of Doses General Population Lecture (6)
Dosage Calculation of Critical Care Medications: mg/min
A change in either volume of distribution or clearance has differing effects on the concentration-time profile. A change in either volume of distribution.
Presentation transcript:

Infusions Mark Tomlin Consultant Pharmacist: Critical Care Southampton University Hospitals NHS Trust

Characteristics of IV therapy Half-Life ? What Dose ? Intermittent Infusion ? How Often ? With Loading Dose ? Continuous Infusion ? Effect of organ dysfunction ?

Concentration – time profile of an IV bolus Concentration Time

Concentration – time profile of an IV bolus Concentration Time An exponential decay C p t = C p 0 x e -kt

Half-life Concentration Time 10 5 tt tt Described by a constant decay factor or:

Half-life - t  Defined as the time taken for the concentration, of a drug, in the blood, to halve. We usually dose at the half-life If the half-life is less than 4 hours then the medicine is usually administered by infusion. After 5 half-lives, the drug is completely eliminated so it describes the duration in the blood Prescribe mg/kg/hr or μg/kg/min to remind staff about response delays after dose adjustments

Characteristics of IV therapy Half-Life ? What Dose ? Intermittent Infusion ? How Often ? With Loading Dose ? Continuous Infusion ? Effect of organ dysfunction ?

Problems with an IV bolus Concentration Time MTC – Minimum Toxic Concentration 24hours

Problems with an IV bolus Concentration Time MEC – Minimum Effective Concentration 24hours

Characteristics of IV therapy Half-Life ? What Dose ? Intermittent Infusion ? How Often ? With Loading Dose ? Continuous Infusion ? Effect of organ dysfunction ?

An Intermittent Infusion Concentration Time MEC – Minimum Effective Concentration 24hours End Infusion MTC – Minimum Toxic Concentration

Characteristics of IV therapy Half-Life ? What Dose ? Intermittent Infusion ? How Often ? With Loading Dose ? Continuous Infusion ? Effect of organ dysfunction ?

How often ? – Intermittent bolus MEC MTC 24 12

How often ? – adjacent bolus MEC MTC 2412

How often ?- accumulating bolus MTC MEC 2412

Characteristics of IV therapy Half-Life ? What Dose ? Intermittent Infusion ? How Often ? With Loading Dose ? Continuous Infusion ? Effect of organ dysfunction ?

Accumulating bolus – with Loading Dose or not? Concentration Time MTC MEC LD How long?

Characteristics of IV therapy Half-Life ? What Dose ? Intermittent Infusion ? How Often ? With Loading Dose ? Continuous Infusion ? Effect of organ dysfunction ?

Short Half-life ? Concentration Time MTC MEC 10 mins

Short Half-life = Infusion Concentration Time MTC MEC 10 mins

Characteristics of IV therapy Half-Life ? What Dose ? Intermittent Infusion ? How Often ? With Loading Dose ? Continuous Infusion ? Effect of organ dysfunction ?

Reduced elimination Concentration Time MEC MTC

Reduced elimination Concentration Time MEC MTC

Extended interval dosing with poor renal perfusion Concentration Time